147 related articles for article (PubMed ID: 34938969)
1. Either transepidermal water loss rates or stratum corneum hydration levels can predict quality of life in children with atopic dermatitis.
Wang S; Shen C; Zhao M; Jiao L; Tian J; Wang Y; Ma L; Man MQ
Pediatr Investig; 2021 Dec; 5(4):277-280. PubMed ID: 34938969
[TBL] [Abstract][Full Text] [Related]
2. Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis.
Hon KL; Wong KY; Leung TF; Chow CM; Ng PC
Am J Clin Dermatol; 2008; 9(1):45-50. PubMed ID: 18092843
[TBL] [Abstract][Full Text] [Related]
3. Dupilumab Improves Skin Barrier Function in Adults with Atopic Dermatitis: A Prospective Observational Study.
Montero-Vilchez T; Rodriguez-Pozo JA; Diaz-Calvillo P; Salazar-Nievas M; Tercedor-Sanchez J; Molina-Leyva A; Arias-Santiago S
J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743415
[TBL] [Abstract][Full Text] [Related]
4. Bleach baths enhance skin barrier, reduce itch but do not normalize skin dysbiosis in atopic dermatitis.
Stolarczyk A; Perez-Nazario N; Knowlden SA; Chinchilli E; Grier A; Paller A; Gill SR; De Benedetto A; Yoshida T; Beck LA
Arch Dermatol Res; 2023 Dec; 315(10):2883-2892. PubMed ID: 37755506
[TBL] [Abstract][Full Text] [Related]
5. Dupilumab Therapy Improves Stratum Corneum Hydration and Skin Dysbiosis in Patients With Atopic Dermatitis.
Lee SJ; Kim SE; Shin KO; Park K; Lee SE
Allergy Asthma Immunol Res; 2021 Sep; 13(5):762-775. PubMed ID: 34486260
[TBL] [Abstract][Full Text] [Related]
6. Children with atopic dermatitis show increased activity of β-glucocerebrosidase and stratum corneum levels of glucosylcholesterol that are strongly related to the local cytokine milieu.
Kezic S; McAleer MA; Jakasa I; Goorden SMI; der Vlugt KG; Beers-Stet FS; Meijer J; Roelofsen J; Nieman MM; van Kuilenburg ABP; Irvine AD
Br J Dermatol; 2022 Jun; 186(6):988-996. PubMed ID: 34993951
[TBL] [Abstract][Full Text] [Related]
7. Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis.
Silverberg JI; Adam DN; Zirwas M; Kalia S; Gutermuth J; Pinter A; Pink AE; Chiricozzi A; Barbarot S; Mark T; Tindberg AM; Weidinger S
Am J Clin Dermatol; 2022 Jul; 23(4):547-559. PubMed ID: 35857179
[TBL] [Abstract][Full Text] [Related]
8. Testing the Actions of a Multi-action Emollient: Patient's Acceptability Determines Product Efficacy.
Hon KL; Kung JSC; Tsang KYC; Yu JWS; Lee VW; Leung TF
Curr Pediatr Rev; 2018; 14(2):110-116. PubMed ID: 29149811
[TBL] [Abstract][Full Text] [Related]
9. Skin pH mapping and its relationship with transepidermal water loss, hydration and disease severity in adult patients with atopic dermatitis.
Zainal H; Jamil A; Md Nor N; Tang MM
Skin Res Technol; 2020 Jan; 26(1):91-98. PubMed ID: 31535769
[TBL] [Abstract][Full Text] [Related]
10. Assessment of serum concentrations of matrix metalloproteinase 1, matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases 1 in atopic dermatitis in correlation with disease severity and epidermal barrier parameters.
Basałygo M; Śliwiñska J; Żbikowska-Gotz M; Lis K; Socha E; Bartuzi Z; Zegarska B
Postepy Dermatol Alergol; 2021 Oct; 38(5):773-779. PubMed ID: 34849123
[TBL] [Abstract][Full Text] [Related]
11. Placebo-controlled, double-blind, randomized, prospective study of a glycerol-based emollient on eczematous skin in atopic dermatitis: biophysical and clinical evaluation.
Breternitz M; Kowatzki D; Langenauer M; Elsner P; Fluhr JW
Skin Pharmacol Physiol; 2008; 21(1):39-45. PubMed ID: 18025807
[TBL] [Abstract][Full Text] [Related]
12. Clinical Signs, Staphylococcus and Atopic Eczema-Related Seromarkers.
Hon KL; Tsang KY; Kung JS; Leung TF; Lam CW; Wong CK
Molecules; 2017 Feb; 22(2):. PubMed ID: 28216598
[TBL] [Abstract][Full Text] [Related]
13. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity.
Chamlin SL; Kao J; Frieden IJ; Sheu MY; Fowler AJ; Fluhr JW; Williams ML; Elias PM
J Am Acad Dermatol; 2002 Aug; 47(2):198-208. PubMed ID: 12140465
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial.
Simpson EL; Silverberg JI; Thyssen JP; Viguier M; Thaçi D; de Bruin-Weller M; Weidinger S; Chan G; DiBonaventura M; Biswas P; Feeney C; Koulias C; Cork MJ
Am J Clin Dermatol; 2023 Jul; 24(4):609-621. PubMed ID: 37213005
[TBL] [Abstract][Full Text] [Related]
15. Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity.
Montero-Vilchez T; Segura-Fernández-Nogueras MV; Pérez-Rodríguez I; Soler-Gongora M; Martinez-Lopez A; Fernández-González A; Molina-Leyva A; Arias-Santiago S
J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33477944
[TBL] [Abstract][Full Text] [Related]
16. Transepidermal water loss measurement during infancy can predict the subsequent development of atopic dermatitis regardless of filaggrin mutations.
Horimukai K; Morita K; Narita M; Kondo M; Kabashima S; Inoue E; Sasaki T; Niizeki H; Saito H; Matsumoto K; Ohya Y
Allergol Int; 2016 Jan; 65(1):103-8. PubMed ID: 26666481
[TBL] [Abstract][Full Text] [Related]
17. Comparison of skin barrier function and sensory nerve electric current perception threshold between IgE-high extrinsic and IgE-normal intrinsic types of atopic dermatitis.
Mori T; Ishida K; Mukumoto S; Yamada Y; Imokawa G; Kabashima K; Kobayashi M; Bito T; Nakamura M; Ogasawara K; Tokura Y
Br J Dermatol; 2010 Jan; 162(1):83-90. PubMed ID: 19785593
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Food Sensitization in Children with Atopic Dermatitis Based on Disease Severity and Epidermal Layer Impairment.
Tran NLH; Ly NTM; Trinh HKT; Le MK; Vo NVT; Pham DL
Int Arch Allergy Immunol; 2024; 185(1):43-55. PubMed ID: 37899044
[TBL] [Abstract][Full Text] [Related]
19. Estimating emollient usage in patients with eczema.
Hon KL; Ching GK; Leung TF; Choi CY; Lee KK; Ng PC
Clin Exp Dermatol; 2010 Jan; 35(1):22-6. PubMed ID: 19489850
[TBL] [Abstract][Full Text] [Related]
20. Severity of disease and the quality of life indexes in infants with atopic dermatitis.
Köse SŞ; Akelma Z; Özmen S
Allergol Immunopathol (Madr); 2022; 50(3):55-61. PubMed ID: 35527656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
